Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1b Multiple Dose Escalation Study of TAB08 in Patients With Advanced Solid Neoplasms

NCT03006029 is registered in ClinicalTrials.gov with Theramab LLC as lead sponsor.

NCT NCT03006029
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03006029 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1b Multiple Dose Escalation Study of TAB08 in Patients With Advanced Solid Neoplasms
Lead sponsor
Theramab LLC
Phase
Phase 1
Overall status
Completed
Start date
February 8, 2017
Completion date
August 13, 2019
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumors